Павел Олегович Бочков
Russian Medical Academy of Continuous Professional Education · 126 works · 443 citations · h-index 11
Top works
- DART mass spectrometry: a fast screening of solid pharmaceuticals for the presence of an active ingredient, as an alternative for IR spectroscopy
- The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty
- Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke
- Effect of CYP3A4, CYP3A5, ABCB1 Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Undergoing Total Hip and Knee Replacement Surgery
- New approach to detecting counterfeit drugs in tablets by DART mass spectrometry
- Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation
- Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease
- Disribution kinetics of cardioprotector ALM-802 in rat organs and tissues
- Capabilities of direct analysis in real time mass spectrometry and gas chromatography–mass spectrometry in the mint oil test
- Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice
- Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats
- Development and Validation of the Quantification of GML-1 Compound (N-benzyl-N-methyl-1-phenylpyrrolo[1,2-A] pyrazine- 3-carbamide) in the Blood Plasma of Rats by HPLC–MS
- Quantification of a potential anticonvulsant drug GIZh-298 in rat plasma by liquid chromatography-mass spectrometry
- CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
- Фармакокинетика потенциального противоэпилептического фармакологического вещества ГИЖ-298 у крыс
- Drug–drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation
- Exome-wide association study of bleeding events in patients receiving direct oral anticoagulants
- An ultra superfast identification of low-molecular components of pharmaceuticals by DART mass spectrometry
- Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease
- New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants